A decade after the first introduction of angiography-derived fractional flow reserve (FFR), we are now entering an era in which simplified image-derived solutions could replace invasive assessment ...
The largest randomized study of fluid intake restrictions showed no benefit from the restrictions, according to its senior ...
• Ultrasound guidance may lead to a higher first-attempt success rate and improved time to successful common femoral artery (CFA) access, while reducing the venipuncture rate (unintentionally ...
Recent innovations in evidence based medicine methods, in particular instruments assessing risk of bias in randomised trials, have focused on methodological rigour at the expense of simplicity and ...
Despite their established effectiveness, uptake of the WHO best buys for tackling non-communicable diseases (NCDs) has been ...
Background The transition to higher education represents a demanding adaptation process with several socioeconomic factors involved. Mental health problems among university students have been ...
A vegan diet rich in low-fat plant-based foods can lead to significant weight loss, regardless of food processing levels, ...
Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...
Background To evaluate the efficacy of early versus delayed introduction of lengthening (ie, eccentric strengthening) exercises in addition to an established rehabilitation programme on return to ...
Sensorion (FR0012596468 - ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 - ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results